Literature DB >> 24735926

SnapShot: Hepatocellular carcinoma.

Jens U Marquardt1, Snorri S Thorgeirsson2.   

Abstract

Hepatocellular carcinoma is the sixth most common cancer globally and the second most lethal cancer worldwide. This SnapShot depicts the molecular and morphological features of this heterogeneous disease, as well as outlines associated prognostic factors, current and emerging therapies, and challenges ahead.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24735926     DOI： 10.1016/j.ccr.2014.04.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  40 in total

1.  Systemic therapy for hepatocellular carcinoma: why do we keep failing?

Authors:  Bo Hyun Kim; Joong-Won Park
Journal:  Hepat Oncol       Date:  2014-12-11

2.  Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma.

Authors:  Hong Zhang; Xiao-Xing Li; Yang Yang; Yanjie Zhang; Hui-Yun Wang; X F Steven Zheng
Journal:  Hepatology       Date:  2018-04-20       Impact factor: 17.425

3.  miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Authors:  Wenjing Mu; Chaobo Hu; Haibin Zhang; Zengqiang Qu; Jin Cen; Zhixin Qiu; Chao Li; Haozhen Ren; Yixue Li; Xianghuo He; Xiaolei Shi; Lijian Hui
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

4.  UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis.

Authors:  Xiyin Huang; Juanyong Pan; Gaoxiong Wang; Tiancong Huang; Chengzong Li; Yanjun Wang; Xinfeng Li
Journal:  Cell Cycle       Date:  2021-10-06       Impact factor: 5.173

Review 5.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

6.  Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications.

Authors:  Xuyu Yang; Xiaoling Zhou; Paul Tone; Marian E Durkin; Nicholas C Popescu
Journal:  Oncol Lett       Date:  2016-06-24       Impact factor: 2.967

7.  Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.

Authors:  Qingqing Wang; Xiaoyan Yu; Zhewen Zheng; Fengxia Chen; Ningning Yang; Yunfeng Zhou
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

8.  Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells.

Authors:  Hui-Chao Zhou; Jian-Hong Fang; Xu Luo; Lei Zhang; Jine Yang; Chong Zhang; Shi-Mei Zhuang
Journal:  Oncotarget       Date:  2014-12-15

9.  ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.

Authors:  Jin Ding; Wen Wen; Daimin Xiang; Peipei Yin; Yanfang Liu; Chang Liu; Guoping He; Zhuo Cheng; Jianpeng Yin; Chunquan Sheng; Wen Zhang; Fajun Nan; Wencai Ye; Xiuli Zhang; Hongyang Wang
Journal:  Oncotarget       Date:  2015-05-10

10.  An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice.

Authors:  Bing-Quan Lin; Wen-Biao Zhang; Jing Zhao; Xu-Hui Zhou; Yong-Jiang Li; Jun Deng; Qin Zhao; Gui Fu; Chuan-Miao Xie; Yi-Kai Xu; Guo-Kai Feng
Journal:  J Hepatocell Carcinoma       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.